Cargando…
Development of relugolix combination therapy as a medical treatment option for women with uterine fibroids or endometriosis
Treatment of uterine fibroids (UF) and endometriosis (EM) has relied on the surgical skills of gynecologists to improve symptoms and potentially alter the course of these debilitating diseases. Medical management of symptoms for both diseases leverages combined hormonal contraceptives used off label...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201285/ https://www.ncbi.nlm.nih.gov/pubmed/37223761 http://dx.doi.org/10.1016/j.xfre.2022.11.010 |